Autophagic/lysosomal dysfunction in Alzheimer's disease

140Citations
Citations of this article
184Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Autophagy serves as the sole catabolic mechanism for degrading organelles and protein aggregates. Increasing evidence implicates autophagic dysfunction in Alzheimer's disease (AD) and other neurodegenerative diseases associated with protein misprocessing and accumulation. Under physiologic conditions, the autophagic/lysosomal system efficiently recycles organelles and substrate proteins. However, reduced autophagy function leads to the accumulation of proteins and autophagic and lysosomal vesicles. These vesicles contain toxic lysosomal hydrolases as well as the proper cellular machinery to generate amyloid-beta, the major component of AD plaques. Here, we provide an overview of current research focused on the relevance of autophagic/lysosomal dysfunction in AD pathogenesis as well as potential therapeutic targets aimed at restoring autophagic/lysosomal pathway function. © 2013 BioMed Central Ltd.

Cite

CITATION STYLE

APA

Orr, M. E., & Oddo, S. (2013). Autophagic/lysosomal dysfunction in Alzheimer’s disease. Alzheimer’s Research and Therapy. https://doi.org/10.1186/alzrt217

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free